Schwenkglenks M

References (2)

Title : Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis - Glinz_2019_Swiss.Med.Wkly_149_w20093
Author(s) : Glinz D , Gloy VL , Monsch AU , Kressig RW , Patel C , McCord KA , Ademi Z , Tomonaga Y , Schwenkglenks M , Bucher HC , Raatz H
Ref : Swiss Med Wkly , 149 :w20093 , 2019
Abstract : Glinz_2019_Swiss.Med.Wkly_149_w20093
ESTHER : Glinz_2019_Swiss.Med.Wkly_149_w20093
PubMedSearch : Glinz_2019_Swiss.Med.Wkly_149_w20093
PubMedID: 31269225

Title : Benzodiazepine Use and Risk of Developing Alzheimer's Disease: A Case-Control Study Based on Swiss Claims Data - Bietry_2017_CNS.Drugs_31_245
Author(s) : Bietry FA , Pfeil AM , Reich O , Schwenkglenks M , Meier CR
Ref : CNS Drugs , 31 :245 , 2017
Abstract : Bietry_2017_CNS.Drugs_31_245
ESTHER : Bietry_2017_CNS.Drugs_31_245
PubMedSearch : Bietry_2017_CNS.Drugs_31_245
PubMedID: 28078633